Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00216333

Recruitment Status : Unknown

Verified September 2006 by International Union Against Tuberculosis and Lung Diseases.
Recruitment status was: Recruiting

First Posted : September 22, 2005

Last Update Posted : September 13, 2006

Sponsor:

Collaborator:

United States Agency for International Development (USAID)

Information provided by:

International Union Against Tuberculosis and Lung Diseases

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Primary Completion Date :	No date given
Study Completion Date :	June 2007

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Lienhardt C, Cook SV, Burgos M, Yorke-Edwards V, Rigouts L, Anyo G, Kim SJ, Jindani A, Enarson DA, Nunn AJ; Study C Trial Group. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled trial. JAMA. 2011 Apr 13;305(14):1415-23. doi: 10.1001/jama.2011.436. Erratum in: JAMA. 2011 Sep 28;306(12):1327.

To Top